BCOR and BCORL1 mutations in pediatric acute myeloid leukemia

• Jasmijn D.E. de Rooij,
• Marry M. van den Heuvel-Eibrink,
• Malou C.H. Hermkens,
• Lonneke J. Verboon,
• Susan T.C.J.M. Arentsen-Peters,
• Maarten Fornerod,
• Andre Baruchel,
• Jan Stary,
• Dirk Reinhardt,
• Valerie de Haas,
• Rob Pieters,
• C. Michel Zwaan

Affiliations

Jasmijn D.E. de Rooij

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Marry M. van den Heuvel-Eibrink

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Malou C.H. Hermkens

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Lonneke J. Verboon

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Susan T.C.J.M. Arentsen-Peters

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Maarten Fornerod

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

Andre Baruchel

CHU de Paris - Hôpital Robert Debré, France

Jan Stary

Pediatric Hematology/Oncology, 2nd Medical School, Charles University, Prague, Czech Republic

Dirk Reinhardt

AML-BFM Study Group, Department of Pediatric Oncology/Hematology, Medical High School, Hannover, Germany

Valerie de Haas

Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands

Rob Pieters

Princess Máxima Center for Pediatric Oncology, Utrectht, The Netherlands

C. Michel Zwaan

Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands